James Royal is a reporter covering investing and wealth management. Before joining Bankrate, he worked as a writer for NerdWallet and a stock analyst …
The news Bankrate's investing reporter is reading this week
Here's what Jim Royal, Bankrate's investing and wealth management reporter, is reading this week.
Photo: www.bankrate.com
Meet Jim
James F. Royal, Ph.D., is a senior reporter for investing at Bankrate, and has been investing in the stock market for more than two decades. Royal is the author of The Zen of Thrift Conversions, and holds a doctorate from the University of Florida.
7 hot IPOs to watch for in 2021
The IPO market was hot in 2020, and it looks set to continue in 2021. Especially popular: SPACs, a special kind of company built for merging with others. Here are the details on some hot 2021 IPOs and some key details about SPACs, too.
A number of hot IPOs hit the market last year, including such highly anticipated names as Airbnb, Snowflake, DoorDash, Palantir and more, as …
Biden's first 100 days and your money
More stimulus checks, anyone? Student loan relief? Eviction moratorium? Here are some of the key things President Biden will be working on in his first 100 days and how they’re going to affect your money. Sarah Foster sums it all up for you and shows you what to watch for.
Familiar challenges await Joe Biden as he becomes the next president of the United States: His earliest days in the White House will be focused on …
higher wages ahead?
A lot of debate swirling around increasing the minimum wage to $15, but in some cases increasing wages is actually more efficient for companies and pays for itself. The details:
Many companies have cut or frozen employees’ pay during the pandemic, but research shows that paying workers more can boost the bottom line. Pay cuts and salary freezes have become an unfortunate hallmark...
What the next gen of vaccines could mean
Second-generation COVID vaccines are on the way, and they could create even better protection than what’s currently on offer, addressing concerns about efficacy and durability of current vaccines.
Six months ago, as the northern hemisphere was still battling the coronavirus pandemic’s first wave, all eyes turned to the COVID-19 vaccines in …
Stay updated on the latest
Insider access to daily trend reports, recommended financial tools and curated news.